317 related articles for article (PubMed ID: 18532911)
21. Mixed-effects statistical model for comparative LC-MS proteomics studies.
Daly DS; Anderson KK; Panisko EA; Purvine SO; Fang R; Monroe ME; Baker SE
J Proteome Res; 2008 Mar; 7(3):1209-17. PubMed ID: 18251496
[TBL] [Abstract][Full Text] [Related]
22. Determination of glycosylation sites and disulfide bond structures using LC/ESI-MS/MS analysis.
Yen TY; Macher BA
Methods Enzymol; 2006; 415():103-13. PubMed ID: 17116470
[TBL] [Abstract][Full Text] [Related]
23. Mass spectrometry detection in comprehensive liquid chromatography: basic concepts, instrumental aspects, applications and trends.
Donato P; Cacciola F; Tranchida PQ; Dugo P; Mondello L
Mass Spectrom Rev; 2012; 31(5):523-59. PubMed ID: 22383300
[TBL] [Abstract][Full Text] [Related]
24. Liquid chromatography-mass spectrometry in food safety.
Malik AK; Blasco C; Picó Y
J Chromatogr A; 2010 Jun; 1217(25):4018-40. PubMed ID: 20392451
[TBL] [Abstract][Full Text] [Related]
25. Characterization of protein impurities and site-specific modifications using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry.
Xie H; Gilar M; Gebler JC
Anal Chem; 2009 Jul; 81(14):5699-708. PubMed ID: 19518054
[TBL] [Abstract][Full Text] [Related]
26. Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure.
Faber MJ; Agnetti G; Bezstarosti K; Lankhuizen IM; Dalinghaus M; Guarnieri C; Caldarera CM; Helbing WA; Lamers JM
Cell Biochem Biophys; 2006; 44(1):11-29. PubMed ID: 16456231
[TBL] [Abstract][Full Text] [Related]
27. The way forward, enhanced characterization of therapeutic antibody glycosylation: comparison of three level mass spectrometry-based strategies.
Wagner-Rousset E; Bednarczyk A; Bussat MC; Colas O; Corvaïa N; Schaeffer C; Van Dorsselaer A; Beck A
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):23-37. PubMed ID: 18672411
[TBL] [Abstract][Full Text] [Related]
28. Mass spectrometric identification of N-linked glycopeptides using lectin-mediated affinity capture and glycosylation site-specific stable isotope tagging.
Kaji H; Yamauchi Y; Takahashi N; Isobe T
Nat Protoc; 2006; 1(6):3019-27. PubMed ID: 17406563
[TBL] [Abstract][Full Text] [Related]
29. Proteomics by FTICR mass spectrometry: top down and bottom up.
Bogdanov B; Smith RD
Mass Spectrom Rev; 2005; 24(2):168-200. PubMed ID: 15389855
[TBL] [Abstract][Full Text] [Related]
30. Assigning glycosylation sites and microheterogeneities in glycoproteins by liquid chromatography/tandem mass spectrometry.
Mechref Y; Madera M; Novotny MV
Methods Mol Biol; 2009; 492():161-80. PubMed ID: 19241032
[TBL] [Abstract][Full Text] [Related]
31. Challenges and strategies for targeted phosphorylation site identification and quantification using mass spectrometry analysis.
Blackburn K; Goshe MB
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):90-103. PubMed ID: 19109306
[TBL] [Abstract][Full Text] [Related]
32. Multivariate analysis of single quadrupole LC-MS spectra for routine characterization and quantification of intact proteins.
Michaud FT; Garnier A; Lemieux L; Duchesne C
Proteomics; 2009 Feb; 9(3):512-20. PubMed ID: 19137552
[TBL] [Abstract][Full Text] [Related]
33. Multidimensional approaches in LC and MS for phospholipid bioanalysis.
Guo X; Lankmayr E
Bioanalysis; 2010 Jun; 2(6):1109-23. PubMed ID: 21083211
[TBL] [Abstract][Full Text] [Related]
34. Integrated analytical strategies for the study of phosphorylation and glycosylation in proteins.
Temporini C; Calleri E; Massolini G; Caccialanza G
Mass Spectrom Rev; 2008; 27(3):207-36. PubMed ID: 18335498
[TBL] [Abstract][Full Text] [Related]
35. Quantification of protein phosphorylation by microLC-ICP-MS.
Krüger R; Zinn N; Lehmann WD
Methods Mol Biol; 2009; 527():201-18, ix. PubMed ID: 19241015
[TBL] [Abstract][Full Text] [Related]
36. Top-down proteomics on a high-field Fourier transform ion cyclotron resonance mass spectrometer.
Ouvry-Patat SA; Torres MP; Gelfand CA; Quek HH; Easterling M; Speir JP; Borchers CH
Methods Mol Biol; 2009; 492():215-31. PubMed ID: 19241035
[TBL] [Abstract][Full Text] [Related]
37. Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment.
Dakna M; He Z; Yu WC; Mischak H; Kolch W
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1250-8. PubMed ID: 19010091
[TBL] [Abstract][Full Text] [Related]
38. An iterative strategy for precursor ion selection for LC-MS/MS based shotgun proteomics.
Zerck A; Nordhoff E; Resemann A; Mirgorodskaya E; Suckau D; Reinert K; Lehrach H; Gobom J
J Proteome Res; 2009 Jul; 8(7):3239-51. PubMed ID: 19402737
[TBL] [Abstract][Full Text] [Related]
39. Multidimensional protein identification technology: current status and future prospects.
Kislinger T; Emili A
Expert Rev Proteomics; 2005 Jan; 2(1):27-39. PubMed ID: 15966850
[TBL] [Abstract][Full Text] [Related]
40. Herbal medicine analysis by liquid chromatography/time-of-flight mass spectrometry.
Zhou JL; Qi LW; Li P
J Chromatogr A; 2009 Oct; 1216(44):7582-94. PubMed ID: 19501368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
